S 23751

Drug Profile

S 23751

Latest Information Update: 03 Nov 2003

Price : $50

At a glance

  • Originator Nonindustrial source; Servier
  • Class Antidepressants; Anxiolytics; Benzopyrans
  • Mechanism of Action Serotonin 1A receptor antagonists; Serotonin 7 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders; Major depressive disorder

Most Recent Events

  • 03 Nov 2003 Discontinued - Preclinical for Anxiety disorders in France (unspecified route)
  • 03 Nov 2003 Discontinued - Preclinical for Depression in France (unspecified route)
  • 24 Aug 2001 No-Development-Reported for Anxiety disorders in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top